Home » Novelos Drug Deal Worth Up to $95 Million
Novelos Drug Deal Worth Up to $95 Million
Novelos Therapeutics has agreed to license and commercialize its lung-cancer drug in a deal that could result in up to $95 million in payments to the cash-strapped pharmaceutical company.
Boston Business Journal
Boston Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May